The global Cardiovascular Monitoring And Diagnostic Devices Market is estimated to be valued at US$ 2,955.1 Mn or Bn in 2023 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cardiovascular monitoring and diagnostic devices are used to monitor heart rate, blood pressure, detect heart arrhythmias and diagnose cardiovascular diseases. These devices provide real-time monitoring of patients heart health and assist clinicians in timely diagnosis and treatment.
Market key trends:
One of the key trends in the Cardiovascular Monitoring And Diagnostic Devices Market Size is growing preference for wireless and wearable cardiovascular monitoring devices. Growing digitization of healthcare and remote/home monitoring is driving the demand for wireless cardiac monitoring solutions. This enables continuous monitoring of patients at home and transfers vital heart health related data to clinicians. Rise in adoption of IoT based cardiac monitoring patches and bands is also a major trend. Furthermore, increasing incidences of cardiovascular diseases due to sedentary lifestyle and growing geriatric population is expected to drive the demand for effective cardiovascular monitoring devices over the forecast period.
Market key trends:
The cardiovascular monitoring and diagnostic devices market is witnessing growing adoption of integrated AI-enabled devices for improved patient care and monitoring. Manufacturers are focusing on developing multi-parameter devices integrated with advanced data analytics capabilities to provide comprehensive patient cardiovascular health insights. Moreover, the rising focus on remote and home healthcare due to the ongoing pandemic is driving demand for wireless, cloud-based monitoring devices.
SWOT Analysis
Strengths:
- Large patient pool and growing demand for cost-effective cardiac care
- Technological advancements in integrated cardiac monitoring devices
Weaknesses:
- High costs of advanced cardiac monitoring systems
- Reimbursement issues related to newly launched cardiac diagnostics
Opportunities:
- Untapped growth potential in emerging markets
- Growing demand for wireless remote patient monitoring solutions
Threats:
- Presence of local manufacturers offering low-cost alternatives
- Stringent regulatory framework for new product approval
Key Takeaways
The global cardiovascular monitoring and diagnostic devices market is expected to witness high growth, exhibiting CAGR of 10.% over the forecast period, due to increasing investments by players as well as governments to develop technologically advanced integrated devices. North America currently dominates the market owing to well-established healthcare systems and early technology adoption in the region.
Regionally, Asia Pacific is expected to exhibit the fastest growth during the forecast period. This can be attributed to growing healthcare expenditure, rising prevalence of cardiovascular diseases, and increasing focus of global players on expanding their presence in emerging Asia Pacific countries.
Key players operating in the cardiovascular monitoring and diagnostic devices market are GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd, Lidco Group plc., Biotricity Inc., Bittium Corporation, VivaQuant.